Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
250
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Lysophosphatidylcholine (17:0) Improves HFD-Induced Hyperglycemia & Insulin Resistance: A Mechanistic Mice Model Study

Li Bao1 Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Bio-Characteristic Profiling for Evaluation of Rational Drug Use, Beijing, People’s Republic of China
,
Ying Zhang2 Beijing Key Laboratory of Bio-Characteristic Profiling for Evaluation of Rational Drug Use, Beijing, People’s Republic of China;3 Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Sichao Yan1 Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Bio-Characteristic Profiling for Evaluation of Rational Drug Use, Beijing, People’s Republic of China
,
Dan Yan2 Beijing Key Laboratory of Bio-Characteristic Profiling for Evaluation of Rational Drug Use, Beijing, People’s Republic of China;3 Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China
&
Dechun Jiang1 Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Bio-Characteristic Profiling for Evaluation of Rational Drug Use, Beijing, People’s Republic of ChinaCorrespondence[email protected]
Pages 3511-3517 | Received 29 Apr 2022, Accepted 05 Sep 2022, Published online: 15 Nov 2022

References

  • Parvez Hossain MD, Bisher Kawar MD, El Nahas M. Obesity and diabetes in the developing world - a growing challenge. New Engl J Med. 2007;356(3):213–215. doi:10.1056/NEJMp068177
  • Rines AK, Sharabi K, Tavares CDJ, et al. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov. 2016;15:786–804. doi:10.1038/nrd.2016.151
  • Després JP, Lemieux I, Alméras N. Abdominal obesity and the metabolic syndrome. In: Bray GA, Ryan DH, editors. Overweight and the Metabolic Syndrome, Endocrine Updates. Boston, MA: Springer; 2006:137–152.
  • Ghislain J, Poitout V. Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges. Nat Rev Endocrinol. 2021;17:162–175. doi:10.1038/s41574-020-00459-w
  • Velazquez-Villegas LA, Perino A, Lemos V, et al. TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue. Nat Commun. 2018;9:245. doi:10.1038/s41467-017-02068-0
  • Li E, Shan H, Chen L, et al. OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metab. 2019;30:319–328. doi:10.1016/j.cmet.2019.05.022
  • Long JL, Yang H, Yang ZR, et al. Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large-scale Chinese patients. Clin Transl Med. 2021;11(6):e432. doi:10.1002/ctm2.432
  • Prada M, Wittenbecher C, Erichelmann F, Wernitz A, Drouin-Chartier JP, Schulze MB. Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: a targeted analysis of lipidomics data in the EPIC-Potsdam cohort. Clin Nutr. 2021;40:4988–4999. doi:10.1016/j.clnu.2021.06.006
  • Drzazga A, Kristinsson H, Sałaga M, et al. Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner. Mol Cell Endocrinol. 2018;472:117–125. doi:10.1016/j.mce.2017.12.002
  • Drzazga A, Sowinska A, Krzeminska A, et al. 2-OMe-lysophosphatidylcholine analogues are GPR119 ligands and activate insulin secretion from βTC-3 pancreatic cells: evaluation of structure-dependent biological activity. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863:91–103. doi:10.1016/j.bbalip.2017.10.004
  • Akbari P, Gilani A, Sosina O, et al. Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity. Science. 2021;373:eabf8683. doi:10.1126/science.abf8683
  • Liu B, Song SS, Ruz-Maldonado I, et al. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans. Diabetes Obes Metab. 2016;18:1263–1273. doi:10.1111/dom.12780
  • Soga T, Ohishi T, Matsui T, et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Bioph Res Co. 2005;326:744–751. doi:10.1016/j.bbrc.2004.11.120
  • Overton HA, Fyfe MCT, Reynet C. GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. Brit J Pharmacol. 2008;153:S76–S81. doi:10.1038/sj.bjp.0707529
  • Abdel-Magid AF. Therapeutic potential of GPR120 agonists for the treatment of type 2 diabetes. ACS Med Chem Lett. 2015;6:1097–1098. doi:10.1021/acsmedchemlett.5b00392
  • Gendaszewska-Darmach E, Drzazga A, Koziołkiewicz M. Targeting GPCRs activated by fatty acid-derived lipids in type 2 diabetes. Trends Mol Med. 2019;25:915–929. doi:10.1016/j.molmed.2019.07.003
  • Murugesan G, Sandhya Rani MR, Gerber CE, et al. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J Mol Cell Cardiol. 2003;35:1375–1384. doi:10.1016/j.yjmcc.2003.08.004
  • Wang L, Radu CG, Yang LV, et al. Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A. Mol Biol Cell. 2005;16:2234–2247. doi:10.1091/mbc.e04-12-1044
  • Yea K, Kim J, Yoon JH, et al. Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes. J Biol Chem. 2009;284:33833–33840. doi:10.1074/jbc.M109.024869
  • Drucker DJ, Habener JF, Holst JJ. Discovery, characterization and clinical development of the glucagon-like peptides. J Clin Invest. 2017;127:4217–4227. doi:10.1172/JCI97233

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.